CDISC SDTM Trial Summary Parameter Short Name Terminology

Preferred Label : CDISC SDTM Trial Summary Parameter Short Name Terminology;

NCIt synonyms : SDTM-TSPARMCD; CDISC SDTM Trial Summary Parameter Terminology;

NCIt related terms : Trial Summary Parameter Test Code; TSPARMCD;

NCIt definition : Terminology codelist used with Trial Summary Parameter within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model.;

Alternative definition : CDISC: The test code for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial.;

Détails

Origin ID

C66738;

UMLS CUI

C1879952;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
concept_is_in_subset
- CDISC SDTM Terminology [NCIt concept]
- Clinical Data Interchange Standards Consortium Terminology [NCIt concept]
subset_includes_concept
- Active Comparator Drug [NCIt concept]
- Actual Subject Number [NCIt concept]
- Adaptive Study Design Indicator [NCIt concept]
- Additional Outcome Measure [NCIt concept]
- Biospecimen Retention Indicator [NCIt concept]
- CDISC Therapeutic Area User Guide Name and Version [NCIt concept]
- CDISC Tobacco Implementation Guide Version [NCIt concept]
- Challenge Agent Name [NCIt concept]
- Clinical Study Citation [NCIt concept]
- Clinical Study End Date [NCIt concept]
- Clinical Study Report Archive Date [NCIt concept]
- Clinical Study Sponsor [NCIt concept]
- Clinical Study by Intent [NCIt concept]
- Clinical Trial Registry Identifier [NCIt concept]
- Clinicaltrials.gov NCT Number for the Expanded Access Record [NCIt concept]
- Confirmed Response Minimum Duration [NCIt concept]
- Control Type [NCIt concept]
- Country of Manufacture [NCIt concept]
- Current Therapy [NCIt concept]
- Data Cutoff Date [NCIt concept]
- Data Cutoff Date Description [NCIt concept]
- Data Monitoring Committee Indicator [NCIt concept]
- Delayed Graft Function Diagnostic Criteria Name [NCIt concept]
- Diagnosis Group [NCIt concept]
- Diagnostic Criteria [NCIt concept]
- Dosage Form Unit [NCIt concept]
- Dose [NCIt concept]
- Dose Frequency [NCIt concept]
- Dose Regimen [NCIt concept]
- E-mail Address for XML File Feedback [NCIt concept]
- ECG Continuous Monitoring Indicator [NCIt concept]
- ECG Evaluator Blinding Parameters [NCIt concept]
- ECG Planned Primary Lead for Study [NCIt concept]
- ECG Read Method Degree of Automation [NCIt concept]
- ECG Replicates On-Treatment Indicator [NCIt concept]
- ECG Replicates at Baseline Indicator [NCIt concept]
- ECG T Wave Algorithm [NCIt concept]
- ECG Used Same Lead Indicator [NCIt concept]
- EMA Decision Number for Pediatric Investigation Plan [NCIt concept]
- Epidemic or Pandemic Related Disruption Indicator [NCIt concept]
- EudraCT Resubmission Indicator [NCIt concept]
- EudraVigilance Sender Identifier [NCIt concept]
- EudraVigilance Sender Organization [NCIt concept]
- Exploratory Outcome Measure [NCIt concept]
- Extension Trial Indicator [NCIt concept]
- FDA Technical Specification Name and Version [NCIt concept]
- FDA-Regulated Device Study Indicator [NCIt concept]
- FDA-Regulated Drug Study Indicator [NCIt concept]
- Healthy Subject Indicator [NCIt concept]
- Intervention Model [NCIt concept]
- Intervention Type [NCIt concept]
- Multiple Site European Union State Trial Indicator [NCIt concept]
- Name of Epidemic or Pandemic [NCIt concept]
- Number of Groups or Cohorts [NCIt concept]
- Number of Trial Sites within European Union State [NCIt concept]
- Observational Model [NCIt concept]
- Observational Study Population Description [NCIt concept]
- Observational Study Sampling Method [NCIt concept]
- Observational Study Sampling Method Description [NCIt concept]
- Observational Time Perspective of Study [NCIt concept]
- Ongoing Study Indicator [NCIt concept]
- Pediatric Investigation Plan Indicator [NCIt concept]
- Pediatric Postmarket Study Indicator [NCIt concept]
- Pediatric Study Indicator [NCIt concept]
- Pharmaceutical Dosage Form [NCIt concept]
- Pharmacological Class of Investigational Therapy [NCIt concept]
- Planned Country of Investigational Site [NCIt concept]
- Planned Follow-Up Duration [NCIt concept]
- Planned Maximum Age of Subjects [NCIt concept]
- Planned Minimum Age of Subjects [NCIt concept]
- Planned Number of Arms [NCIt concept]
- Planned Subject Number [NCIt concept]
- Planned Treatment Duration [NCIt concept]
- Planned Trial Duration [NCIt concept]
- Post Authorization Safety Study Indicator [NCIt concept]
- Primary Outcome Measure [NCIt concept]
- Protocol Agent [NCIt concept]
- Protocol Keyword [NCIt concept]
- Protocol Risk Assessment [NCIt concept]
- PubMed Unique Identifier [NCIt concept]
- Randomization [NCIt concept]
- Randomization Quotient [NCIt concept]
- Rare Disease Indicator [NCIt concept]
- Relapse Criteria [NCIt concept]
- Requires Secure Email Delivery of XML Indicator [NCIt concept]
- Resubmission Letter [NCIt concept]
- Retained Biospecimen Contains DNA Indicator [NCIt concept]
- Retained Biospecimen Description [NCIt concept]
- Route of Administration [NCIt concept]
- SDTM Implementation Guide Medical Device Version [NCIt concept]
- SUSAR Reporting to EudraVigiliance Clinical Trial Module Indicator [NCIt concept]
- SUSAR Reporting to National Competent Authority Indicator [NCIt concept]
- Secondary Outcome Measure [NCIt concept]
- Severity Criteria [NCIt concept]
- Sex of Study Group [NCIt concept]
- Single Site European Union State Trial Indicator [NCIt concept]
- Sponsor Commercial Status [NCIt concept]
- Sponsor Study Reference Identifier [NCIt concept]
- Stable Disease Minimum Duration [NCIt concept]
- Stratification Factors [NCIt concept]
- Study Contact E-mail Address [NCIt concept]
- Study Contact Name [NCIt concept]
- Study Contact Postal Address [NCIt concept]
- Study Contact Role [NCIt concept]
- Study Contact Telephone Number [NCIt concept]
- Study Data Tabulation Model Implementation Guide Version [NCIt concept]
- Study Data Tabulation Model Version [NCIt concept]
- Study Protocol Uniform Resource Locator [NCIt concept]
- Study Protocol Uniform Resource Locator Description [NCIt concept]
- Study Saved as XML Indicator [NCIt concept]
- Study Start Date [NCIt concept]
- Study Stop Rule [NCIt concept]
- Study Type [NCIt concept]
- Substudy Details [NCIt concept]
- Substudy Planned Indicator [NCIt concept]
- Test Product Added to Existing Treatment [NCIt concept]
- Therapeutic Area [NCIt concept]
- Tobacco Product [NCIt concept]
- Trial Blinding Schema [NCIt concept]
- Trial Expanded Access Status [NCIt concept]
- Trial Exploratory Objective [NCIt concept]
- Trial Indication [NCIt concept]
- Trial Length [NCIt concept]
- Trial Phase [NCIt concept]
- Trial Primary Objective [NCIt concept]
- Trial Secondary Objective [NCIt concept]
- Trial Title [NCIt concept]
- Trial Type [NCIt concept]
- US FDA Tobacco Product Applicant [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients